Acetic acid is the acid of vinegar, used dilute in peptide work to lower the diluent's pH for peptides that dissolve poorly in neutral water.
What published studies and recent community write-ups report about amounts, timing and course length. 1 clinical and 6 community-reported rows, each linked to its source. These are descriptions of what others report, not instructions, and nothing here is medical advice.
| Context | Dose | Frequency | Route | Course | Source |
|---|---|---|---|---|---|
| Clinical1 row | |||||
| The only licensed sterile acetic acid solution: 0.25% urologic irrigantPatients with a long-term indwelling urinary catheter | 250 mg glacial acetic acid per 100 mL water for injection (0.25%), pH 3.1 (2.8 to 3.4), 42 mOsmol/L | Constant or intermittent bladder rinse | Irrigation only; the label states in capitals that it is not for injection | Single-dose containers, unused portion discardedNot applicable | DailyMed, National Library of Medicine2023 |
| This label is here to settle a question, not to describe a peptide protocol: the one acetic acid preparation that is sterile, pyrogen-free and regulated is a bladder irrigant whose contraindications section reads simply that it is not for injection. It is hypotonic and contains no preservative or buffer. Any acetic acid water sold as an injectable peptide diluent sits outside this and every other licence. | |||||
| Community-reported6 rows | |||||
| Manufacturer solubility guideline: basic peptides | Water first; if that fails, 10% to 30% acetic acid; if that fails, a small amount of DMSO, then dilute to the working concentration | Once, on a small test aliquot before committing the vial | Bench dissolution for laboratory use | Not stated | Community resource2023 |
| A peptide synthesis supplier's guideline, written for laboratory users rather than injection. It assigns +1 to each arginine, lysine, histidine and the N-terminus and -1 to each aspartate, glutamate and the C-terminus, and routes peptides with a net positive charge to acidic solvents. Peptides under six residues are expected to dissolve in plain water. This is the chemistry behind the community habit of reaching for acid; the percentages here are far stronger than the 0.1% to 0.6% community diluents and are meant to be diluted away afterwards. | |||||
| Manufacturer solubility guideline: charge-based solvent choice | Positively charged peptides: 10% acetic acid, with under 50 microlitres of TFA if needed; negatively charged: aqueous ammonia or 10% ammonium bicarbonate; neutral or hydrophobic: a small volume of DMSO first | Once, stepwise, vortexing or sonicating after each addition | Bench dissolution for laboratory use | Not stated | Community resource2026 |
| The second supplier guideline agrees with the first on the rule and adds the mirror image: acidic peptides want a base, not an acid. It also caps DMSO at about 1% of the final working solution for most assays. For a peptide user the practical lesson is that acid is the right tool only for one class of sequence; applied to the wrong class it does nothing or does harm. | |||||
| Technical guide: dilute acid as a working diluent | 0.1% v/v acetic acid, approximately pH 3.5, for basic peptides with substantial hydrophobic content | As the primary solvent after water or bacteriostatic water has failed | Bench dissolution | Not stated | Community resource2026 |
| This guide explains the mechanism in one sentence: at acidic pH every basic residue is protonated, maximising positive charge and the electrostatic repulsion that keeps molecules apart, and the acetate counter-ion is inert at these concentrations. Its decision tree starts with the vendor's certificate of analysis, then net charge: above +2 try water then 0.1% acetic acid; below -2 try water then 0.1% ammonium hydroxide; near zero choose by which way the sequence leans. | |||||
| Vendor reconstitution guide: acid first, then bacteriostatic water | 0.1-0.2 mL of about 0.6% acetic acid water (pH about 3.0) down the vial wall, swirled one to two minutes, then diluted to the working volume with bacteriostatic water | Once, at reconstitution | Two-step reconstitution of an injectable vial | Keep the finished solution below about pH 7.5 for copper peptidesNot applicable | Community resource2026 |
| This is a peptide vendor's own instruction, so it is a vendor claim. It names the peptides in its catalogue that get the two-step treatment: GHK-Cu and the copper-containing GLOW blend, plus hydrophobic sequences it says clump at neutral pH, such as AOD-9604, the melanotans and Dihexa. Everything else is dissolved in bacteriostatic water alone. The order matters in its account: dissolve in a little acid, then add the preserved water so the bacteriostatic agent is still present for storage. | |||||
| Forum thread: acidified bacteriostatic water for cagrilintide | A supplier's bacteriostatic water at pH 7.22 versus its acetic acid version at pH 3.3; one member targeted pH 3.5 to 4 for cagrilintide, another measured pH 5.0 to 5.25 using bacteriostatic saline | Once, at reconstitution, with pH strips to check | Subcutaneous use discussed by members | Not stated | Community resource2024 |
| A 2024 forum exchange in which members reason about which diluent suits which peptide. The consensus offered is that acid is for peptides that want a low pH, cagrilintide being the much-debated example, while sodium bicarbonate is for peptides that are too acidic such as unbuffered NAD+. Members warn that a solution at pH 3.5 to 4 stings on injection and that cagrilintide solutions should be filtered for fibrils. One contributor explicitly disclaims expertise. None of this is a protocol; it is a record of what people describe doing and worrying about. | |||||
| Community explainer and the dissent beneath it | Acidic reconstitution recommended by the post for vials kept longer than about 2 weeks; bacteriostatic water alone for use within 7 to 14 days if the peptide dissolves fully | Once, at reconstitution, often acid first then bacteriostatic water | Subcutaneous use discussed | Not stated | Community resource2026 |
| The post argues that some peptides need acidic pH to dissolve and stay stable, that a mild sting is expected from a low-pH solution, and that diluting with bacteriostatic water after dissolution reduces it. The most useful content is a dissenting comment: GHK-Cu should not go in acid because the copper salts out, leaving plain GHK and copper acetate; NAD+ is the last thing that needs acid and wants a carbonate or bicarbonate buffer to pH 5.5 to 6 instead; and bacteriostatic water is already slightly acidic, which is why it works for most peptides. The thread is a good illustration that community acid advice is contested, not settled. | |||||
Community and vendor guides add a small volume, about 0.1 to 0.2 mL, of dilute acetic acid water down the vial wall and swirl until the powder clears, typically one to two minutes. The acid is doing one job: protonating basic residues so the peptide dissolves.
The dissolved peptide is brought to its working volume with bacteriostatic water, which supplies the preservative for storage and raises the pH part of the way back, reducing the sting that an undiluted acidic solution produces on injection.
Supplier guidelines test a small aliquot first, use much stronger acid (10% to 30%) only on peptides whose net charge calls for it, and dilute it away afterwards. They never describe injecting the result; that step belongs entirely to community practice.
Plus 6 community resources (dosing guides, forum threads and vendor write-ups), reported above but not linked.
Acetic acid is the acid of vinegar, used dilute in peptide work to lower the diluent's pH for peptides that dissolve poorly in neutral water. Most lyophilised research peptides are supplied as acetate salts and dissolve in bacteriostatic water alone; the exceptions are strongly basic or hydrophobic sequences and some copper complexes, which supplier guidance and community guides dissolve first in a small volume of dilute acid before topping up with bacteriostatic water. No acetic acid solution is licensed for injection at any strength: the only labelled sterile product is a 0.25% urologic irrigant marked not for injection, so every injectable use described below is a research or community practice rather than an approved one.
These themes describe recurring questions in published research. They are not claims of effectiveness or recommendations for use.
Diluents and buffers a lyophilised vial is dissolved in.
This label is here to settle a question, not to describe a peptide protocol: the one acetic acid preparation that is sterile, pyrogen-free and regulated is a bladder irrigant whose contraindications section reads.
A peptide synthesis supplier's guideline, written for laboratory users rather than injection. It assigns +1 to each arginine, lysine, histidine and the N-terminus and -1 to each aspartate, glutamate and the C-terminus.
The second supplier guideline agrees with the first on the rule and adds the mirror image: acidic peptides want a base, not an acid. It also caps DMSO at about 1% of the final working solution for most assays. For a.
This guide explains the mechanism in one sentence: at acidic pH every basic residue is protonated, maximising positive charge and the electrostatic repulsion that keeps molecules apart, and the acetate counter-ion is.
This is a peptide vendor's own instruction, so it is a vendor claim. It names the peptides in its catalogue that get the two-step treatment: GHK-Cu and the copper-containing GLOW blend, plus hydrophobic sequences it.
Study models remain visible so laboratory and animal findings are not mistaken for established human outcomes.
1 protocol row on this page come from human trials, trial registrations, regulator labels or reviews of human data. Approval status and populations are stated per row.
6 rows record what blogs, vendor write-ups or forums describe for Acetic Acid. None has been verified against primary literature.
Sequence, synonyms and registry identifiers as recorded in PubChem, the National Library of Medicine's open chemistry database. Formula, mass and CAS number are summarized at the top of the page.
Ethanoic acid, Glacial acetic acid, Acetic acid water, E260, UNII Q40Q9N063P
QTBSBXVTEAMEQO-UHFFFAOYSA-N
acetic acid
2 curated references, each with its journal, year and study model, plus 6 community resources reported but not linked.